MRNA spotlight — 2026-10-19
Moderna shares fell 7.82% during Friday's session, closing at $218.01. This price drop contrasts with recent news sentiment, which skews positive with four positive and zero negative ratings.
Key figures
Data as of Oct 19, 2026- MRNA last close
- $218.01
- MRNA change vs prior close
- -7.82%
- MRNA market cap
- $85.82B
Moderna shares fell 7.82%¹ during Friday's session, closing at $218.01². This price drop contrasts with recent news sentiment, which skews positive with four positive and zero negative ratings.
Despite Friday's decline, the stock remains near the top of its 52-week range at 89.0%³, having climbed 686.47% over the last 12 months⁴. This growth is reflected in a current market cap of $85.82B⁵ and a price that sits 181.68% above its 200-day average⁶.
However, the company's latest financial reports show a lack of profitability, with a reported EPS of -1.97⁷ on revenue of $145.00M⁸. Trading volume on Friday reached 21.43 million shares⁹, which is 1.17x the 20-session average¹⁰.
Moderna, Inc. Common Stock (MRNA): price and news
Full chart and figuresEducational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.